RYTHM (RYM) and Its Rivals Financial Comparison

RYTHM (NASDAQ:RYMGet Free Report) is one of 902 public companies in the “Pharmaceuticals” industry, but how does it weigh in compared to its peers? We will compare RYTHM to similar companies based on the strength of its dividends, earnings, analyst recommendations, risk, profitability, institutional ownership and valuation.

Insider & Institutional Ownership

6.0% of RYTHM shares are owned by institutional investors. Comparatively, 32.6% of shares of all “Pharmaceuticals” companies are owned by institutional investors. 3.5% of RYTHM shares are owned by insiders. Comparatively, 14.1% of shares of all “Pharmaceuticals” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations for RYTHM and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RYTHM 1 0 0 0 1.00
RYTHM Competitors 7573 13639 25435 998 2.42

As a group, “Pharmaceuticals” companies have a potential upside of 33.48%. Given RYTHM’s peers stronger consensus rating and higher possible upside, analysts plainly believe RYTHM has less favorable growth aspects than its peers.

Valuation & Earnings

This table compares RYTHM and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
RYTHM $17.28 million -$33.26 million -2.06
RYTHM Competitors $3.50 billion $3.14 billion 551.06

RYTHM’s peers have higher revenue and earnings than RYTHM. RYTHM is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares RYTHM and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
RYTHM -6.20% -12.57% -2.60%
RYTHM Competitors -2,309.62% -223.14% -17.45%

Risk & Volatility

RYTHM has a beta of 9.44, suggesting that its stock price is 844% more volatile than the S&P 500. Comparatively, RYTHM’s peers have a beta of -3.15, suggesting that their average stock price is 415% less volatile than the S&P 500.

Summary

RYTHM peers beat RYTHM on 9 of the 13 factors compared.

RYTHM Company Profile

(Get Free Report)

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.

Receive News & Ratings for RYTHM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RYTHM and related companies with MarketBeat.com's FREE daily email newsletter.